When BC cells arrive in secondary organs, MET is activated, and BC cells start to re-express epithelial markers, such as E-cadherin, occludin and crumbs3, and down-regulate mesenchymal transcription factors [90]. This evidence concerns the gene OCLN and breast cancer.